Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-26 @ 1:52 AM
Study NCT ID:
NCT00077857
Status:
COMPLETED
Last Update Posted:
2013-05-10
First Post:
2004-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-02-12
First Submit QC Date:
None
Study First Post Date:
2004-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-02-13
Results First Submit QC Date:
None
Results First Post Date:
2013-05-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-27
Last Update Post Date:
2013-05-10
Last Update Post Date Type:
ESTIMATED